The IRESSA Novel Head and Neck Chemotherapy Evaluation Study

Clinical trial NCT00255476 · COMPLETED

Trial details

NCT number: NCT00255476
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Cancer Cancer of Head and Neck

Start date: 2004-02-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.